2024-11-012025-10-312025-10-31false15232883CLEMATIS HOLDINGS UK LIMITED2026-07-31falseiso4217:GBPxbrli:pure152328832024-10-31152328832025-10-31152328832024-11-012025-10-31152328832023-10-23152328832024-10-31152328832023-10-242024-10-3115232883bus:SmallEntities2024-11-012025-10-3115232883bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3115232883bus:FullAccounts2024-11-012025-10-3115232883bus:PrivateLimitedCompanyLtd2024-11-012025-10-3115232883core:WithinOneYear2025-10-3115232883core:AfterOneYear2025-10-3115232883core:WithinOneYear2024-10-3115232883core:AfterOneYear2024-10-3115232883core:ShareCapital2025-10-3115232883core:SharePremium2025-10-3115232883core:RevaluationReserve2025-10-3115232883core:OtherReservesSubtotal2025-10-3115232883core:RetainedEarningsAccumulatedLosses2025-10-3115232883core:ShareCapital2024-10-3115232883core:SharePremium2024-10-3115232883core:RevaluationReserve2024-10-3115232883core:OtherReservesSubtotal2024-10-3115232883core:RetainedEarningsAccumulatedLosses2024-10-3115232883core:LandBuildings2025-10-3115232883core:PlantMachinery2025-10-3115232883core:Vehicles2025-10-3115232883core:FurnitureFittings2025-10-3115232883core:OfficeEquipment2025-10-3115232883core:NetGoodwill2025-10-3115232883core:IntangibleAssetsOtherThanGoodwill2025-10-3115232883core:ListedExchangeTraded2025-10-3115232883core:UnlistedNon-exchangeTraded2025-10-3115232883core:LandBuildings2024-10-3115232883core:PlantMachinery2024-10-3115232883core:Vehicles2024-10-3115232883core:FurnitureFittings2024-10-3115232883core:OfficeEquipment2024-10-3115232883core:NetGoodwill2024-10-3115232883core:IntangibleAssetsOtherThanGoodwill2024-10-3115232883core:ListedExchangeTraded2024-10-3115232883core:UnlistedNon-exchangeTraded2024-10-3115232883core:LandBuildings2024-11-012025-10-3115232883core:PlantMachinery2024-11-012025-10-3115232883core:Vehicles2024-11-012025-10-3115232883core:FurnitureFittings2024-11-012025-10-3115232883core:OfficeEquipment2024-11-012025-10-3115232883core:NetGoodwill2024-11-012025-10-3115232883core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3115232883core:ListedExchangeTraded2024-11-012025-10-3115232883core:UnlistedNon-exchangeTraded2024-11-012025-10-3115232883core:MoreThanFiveYears2024-11-012025-10-3115232883core:Non-currentFinancialInstruments2025-10-3115232883core:Non-currentFinancialInstruments2024-10-3115232883dpl:CostSales2024-11-012025-10-3115232883dpl:DistributionCosts2024-11-012025-10-3115232883core:LandBuildings2024-11-012025-10-3115232883core:PlantMachinery2024-11-012025-10-3115232883core:Vehicles2024-11-012025-10-3115232883core:FurnitureFittings2024-11-012025-10-3115232883core:OfficeEquipment2024-11-012025-10-3115232883dpl:AdministrativeExpenses2024-11-012025-10-3115232883core:NetGoodwill2024-11-012025-10-3115232883core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3115232883dpl:GroupUndertakings2024-11-012025-10-3115232883dpl:ParticipatingInterests2024-11-012025-10-3115232883dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3115232883core:ListedExchangeTraded2024-11-012025-10-3115232883dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3115232883core:UnlistedNon-exchangeTraded2024-11-012025-10-3115232883dpl:CostSales2023-10-242024-10-3115232883dpl:DistributionCosts2023-10-242024-10-3115232883core:LandBuildings2023-10-242024-10-3115232883core:PlantMachinery2023-10-242024-10-3115232883core:Vehicles2023-10-242024-10-3115232883core:FurnitureFittings2023-10-242024-10-3115232883core:OfficeEquipment2023-10-242024-10-3115232883dpl:AdministrativeExpenses2023-10-242024-10-3115232883core:NetGoodwill2023-10-242024-10-3115232883core:IntangibleAssetsOtherThanGoodwill2023-10-242024-10-3115232883dpl:GroupUndertakings2023-10-242024-10-3115232883dpl:ParticipatingInterests2023-10-242024-10-3115232883dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-242024-10-3115232883core:ListedExchangeTraded2023-10-242024-10-3115232883dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-242024-10-3115232883core:UnlistedNon-exchangeTraded2023-10-242024-10-3115232883core:NetGoodwill2025-10-3115232883core:IntangibleAssetsOtherThanGoodwill2025-10-3115232883core:LandBuildings2025-10-3115232883core:PlantMachinery2025-10-3115232883core:Vehicles2025-10-3115232883core:FurnitureFittings2025-10-3115232883core:OfficeEquipment2025-10-3115232883core:AfterOneYear2025-10-3115232883core:WithinOneYear2025-10-3115232883core:ListedExchangeTraded2025-10-3115232883core:UnlistedNon-exchangeTraded2025-10-3115232883core:ShareCapital2025-10-3115232883core:SharePremium2025-10-3115232883core:RevaluationReserve2025-10-3115232883core:OtherReservesSubtotal2025-10-3115232883core:RetainedEarningsAccumulatedLosses2025-10-3115232883core:NetGoodwill2024-10-3115232883core:IntangibleAssetsOtherThanGoodwill2024-10-3115232883core:LandBuildings2024-10-3115232883core:PlantMachinery2024-10-3115232883core:Vehicles2024-10-3115232883core:FurnitureFittings2024-10-3115232883core:OfficeEquipment2024-10-3115232883core:AfterOneYear2024-10-3115232883core:WithinOneYear2024-10-3115232883core:ListedExchangeTraded2024-10-3115232883core:UnlistedNon-exchangeTraded2024-10-3115232883core:ShareCapital2024-10-3115232883core:SharePremium2024-10-3115232883core:RevaluationReserve2024-10-3115232883core:OtherReservesSubtotal2024-10-3115232883core:RetainedEarningsAccumulatedLosses2024-10-3115232883core:NetGoodwill2023-10-2315232883core:IntangibleAssetsOtherThanGoodwill2023-10-2315232883core:LandBuildings2023-10-2315232883core:PlantMachinery2023-10-2315232883core:Vehicles2023-10-2315232883core:FurnitureFittings2023-10-2315232883core:OfficeEquipment2023-10-2315232883core:AfterOneYear2023-10-2315232883core:WithinOneYear2023-10-2315232883core:ListedExchangeTraded2023-10-2315232883core:UnlistedNon-exchangeTraded2023-10-2315232883core:ShareCapital2023-10-2315232883core:SharePremium2023-10-2315232883core:RevaluationReserve2023-10-2315232883core:OtherReservesSubtotal2023-10-2315232883core:RetainedEarningsAccumulatedLosses2023-10-2315232883core:AfterOneYear2024-11-012025-10-3115232883core:WithinOneYear2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3115232883core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3115232883core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3115232883core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3115232883core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3115232883core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3115232883bus:Director12024-11-012025-10-3115232883bus:Director22024-11-012025-10-31152328831bus:Director12024-10-31152328831bus:Director12024-11-012025-10-31152328831bus:Director12025-10-31152328832024-10-31152328832024-11-012025-10-31152328832025-10-31

CLEMATIS HOLDINGS UK LIMITED

Registered Number
15232883
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

CLEMATIS HOLDINGS UK LIMITED
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

ALAGHBAND, Niloofar
ALAGHBAND, Yasmin

Registered Address

C/O 3dom.Uk Accountants Ltd
Second Floor, 61 Hamilton Square
Birkenhead
CH41 5AT

Registered Number

15232883 (England and Wales)
CLEMATIS HOLDINGS UK LIMITED
Statement of Financial Position
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Investment property310,350,00010,350,000
10,350,00010,350,000
Current assets
Debtors4,5866,299-
Cash at bank and on hand218,09270,246
1,084,39170,246
Creditors amounts falling due within one year6(721,143)(149,117)
Net current assets (liabilities)363,248(78,871)
Total assets less current liabilities10,713,24810,271,129
Creditors amounts falling due after one year7(10,750,381)(10,350,000)
Net assets(37,133)(78,871)
Capital and reserves
Called up share capital44
Profit and loss account(37,137)(78,875)
Shareholders' funds(37,133)(78,871)
The financial statements were approved and authorised for issue by the Board of Directors on 31 July 2026, and are signed on its behalf by:
ALAGHBAND, Niloofar
Director
Registered Company No. 15232883
CLEMATIS HOLDINGS UK LIMITED
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below. Valuation of investment property There are a number of estimates involved in assessing the fair value of the company's investment property. The directors have determined the fair value on similar properties at the same location. The carrying amount is £10,350,000.
Turnover policy
Turnover comprises the fair value of the consideration received or receivable from the rental of investment properties in the ordinary course of the Company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. The Company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the Company's activities.
Borrowing costs
Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale. Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation.
Finance costs
Finance costs charged to the profit or loss include interest expense calculated using the effective interest method from FRS 102:11, finance charges on finance leases, and exchange differences on foreign currency borrowings where these are treated as an adjustment to interest costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable. Corporation tax under section 455 Corporation Tax Act 2010 is payable on loans made to participators and their associates which remain outstanding nine months and one day after the end of the accounting period. The tax is recoverable under section 458 when the loans are repaid, released or written off. The company recognises the liability to HM Revenue and Customs together with a corresponding asset representing the amount recoverable, as recovery is considered probable. No charge is made to the profit and loss account. The asset is classified as falling due after more than one year as recovery is not expected within twelve months of the balance sheet date.
Investment property
Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by the directors. The directors use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees
The company had no employees other than the directors during the period.

20252024
Average number of employees during the year00
3.Investment property
The company holds one investment property, which is measured at fair value in accordance with FRS 102 Section 16. The property was acquired during the year ended 31 October 2024. The fair value at initial recognition and at 31 October 2025 was £10,350,000. The valuation was determined by the directors based on available market evidence, including prices of comparable properties in the same location, adjusted for differences in condition and other relevant factors. The company applies the fair value model. Accordingly, no depreciation is charged. Changes in fair value are recognised in profit or loss in the period in which they arise. The valuation is reviewed annually.

£
Fair value at 01 November 2410,350,000
At 31 October 2510,350,000
4.Debtors: amounts due within one year

2025

2024

££
Other debtors866,299-
Total866,299-
Other debtors comprise a loan of £88,700 to a director and a loan of £559,000 to an associate of the participators. The loans are interest free, unsecured and have no fixed date of repayment. Further details are given in notes 10 and 12.
5.Debtors: amounts due after one year
Amounts falling due after more than one year: section 455 tax recoverable £218,598.75 (2024: nil).
6.Creditors: amounts due within one year

2025

2024

££
Taxation and social security218,599-
Other creditors423,99975,000
Accrued liabilities and deferred income78,54574,117
Total721,143149,117
Deferred income of £72,453 has been recognised, representing rent received in advance relating to periods after the year-end. Corporation tax £218,598.75 (2024: nil), representing tax under section 455 CTA 2010 on loans to a participator and to an associate of the participators, payable on 1 August 2026.
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts6,099,8815,600,000
Amounts owed to related parties4,650,5004,750,000
Total10,750,38110,350,000
8.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
ALAGHBAND, Niloofar088,700088,700
088,700088,700
During the year the company advanced £88,700 to N Alaghband, a director. The balance outstanding at 31 October 2025 was £88,700 (2024: nil). As the loan remained outstanding nine months and one day after the year end, tax of £29,936.25 is payable under section 455 CTA 2010. At 31 October 2025 the company owed £349,000 to Y Alaghband, a director (2024: nil). During the year she advanced £368,000 and was repaid £19,000.
9.Share capital
The company issued 4 ordinary shares of £1 each. These shares were allotted but not paid up and are treated as unpaid share capital.
10.Related party transactions
For the purposes of these financial statements, a related party may be a person or entity with control, joint control, or significant influence over the company. The directors have considered the definition of a related party under FRS 102 to ensure that all relevant relationships, transactions and balances are disclosed appropriately. During the year the company advanced £559,000 to F Afsharnia, a related party. The balance outstanding at 31 October 2025 was £559,000 (2024:nil). As the loan remained outstanding nine months and one day after the year end, tax of £188,662.50 is payable under section 455 CTA 2010. The company owes £4,650,500 to Clematis Holdings Limited, its wholly owned subsidiary (2024: £4,750,000). During the year the company settled liabilities of £99,500 on that company's behalf.
11.Controlling party
The company is controlled by N Alaghband and Y Alaghband, each of whom holds 50% of the issued share capital of the company. In the opinion of the directors there is no single ultimate controlling party.